Lowes Companies Inc
—- Market cap
- $110.30B
- Debt
- —
- Cash
- −$982.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $110.30B · View financials
Snapshot Sep 10, 2026, 4:00 PM ET
FY 2026 ·
Decision snapshot: LOW stock price at discount vs TECH $196.59 current versus $736.33 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TECH's multiple
Implied fair value · at LOW's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LOWES COMPANIES INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
BIO-TECHNE Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HOME DEPOT, INC.
LOW vs HD
SHERWIN WILLIAMS CO
LOW vs SHW
WILLIAMS SONOMA INC
LOW vs WSM
Tractor Supply Company
LOW vs TSCO
THERMO FISHER SCIENTIFIC INC.
LOW vs TMO
DANAHER CORP /DE/
LOW vs DHR
AGILENT TECHNOLOGIES, INC.
LOW vs A
WATERS CORP /DE/
LOW vs WAT
ILLUMINA, INC.
LOW vs ILMN
BRUKER CORP
LOW vs BRKR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LOW's slower growth and mixed quality metrics are already reflected in its much lower valuation multiples, then owning or adding LOW makes sense because it trades at 19.2x P/E and 1.5x P/S versus TECH's 154.0x and 9.1x, while still producing much larger absolute earnings.
LOW trades at a large valuation discount to TECH-implied P/E-based price, with the model showing $227.50 versus an implied $1,824.64. The gap is driven by TECH's much richer multiples rather than stronger scale, since LOW is the much larger business by revenue and net income.
Supporting Metrics